Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients.

Nagano K, Kanasaki S, Yamashita T, Maeda Y, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

Cancer Med. 2013 Dec;2(6):972-7. doi: 10.1002/cam4.156. Epub 2013 Nov 7.

2.

Eph receptor A10 has a potential as a target for a prostate cancer therapy.

Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):545-9. doi: 10.1016/j.bbrc.2014.06.007. Epub 2014 Jun 9.

PMID:
24924629
3.

Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.

Wu QW, Yang QM, Huang YF, She HQ, Liang J, Yang QL, Zhang ZM.

PLoS One. 2014 May 20;9(5):e97804. doi: 10.1371/journal.pone.0097804. eCollection 2014.

4.

Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.

Nakagawa M, Inokuchi M, Takagi Y, Kato K, Sugita H, Otsuki S, Kojima K, Uetake H, Sugihara K.

Ann Surg Oncol. 2015 Jul;22(7):2329-35. doi: 10.1245/s10434-014-4231-3. Epub 2014 Nov 13.

PMID:
25391265
5.

Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.

Fu DY, Tan HS, Wei JL, Zhu CR, Jiang JX, Zhu YX, Cai FL, Chong MH, Ren CL.

Tumour Biol. 2015 Sep;36(10):8025-34. doi: 10.1007/s13277-015-3547-3. Epub 2015 May 14.

PMID:
25971583
6.

Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.

Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM.

BMC Cancer. 2012 Jan 27;12:47. doi: 10.1186/1471-2407-12-47.

7.

Association of chemotactic factor receptor 5 gene with breast cancer.

Zhang Y, Meng FY, Li WL, Zhou CX, Guan Z, Fan HY.

Genet Mol Res. 2013 Nov 7;12(4):5289-300. doi: 10.4238/2013.November.7.4.

8.

Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.

Liu YJ, Yan PS, Li J, Jia JF.

World J Gastroenterol. 2005 Nov 14;11(42):6601-6.

9.

OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival.

Ou-Yang QH, Duan ZX, Jin Z, Lei JX.

Tumour Biol. 2014 Sep;35(9):8823-7. doi: 10.1007/s13277-014-2130-7. Epub 2014 Jun 1.

PMID:
24880589
10.

Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.

Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G, Lu G, Sugimura H, Zhou X.

Oncol Rep. 2010 Dec;24(6):1577-84.

PMID:
21042754
11.

Overexpression of ILK1 in breast cancer associates with poor prognosis.

Yang HJ, Zheng YB, Ji T, Ding XF, Zhu C, Yu XF, Ling ZQ.

Tumour Biol. 2013 Dec;34(6):3933-8. doi: 10.1007/s13277-013-0981-y. Epub 2013 Jul 7.

PMID:
23832543
12.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Nagano K, Maeda Y, Kanasaki S, Watanabe T, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

J Control Release. 2014 Sep 10;189:72-9. doi: 10.1016/j.jconrel.2014.06.010. Epub 2014 Jun 16.

PMID:
24946238
13.

[Expression of tyrosine kinase Syk in breast cancer and their clinical significance].

Ding YB, Wu ZY, Wang S, Fan P, Zha XM, Zheng W, Liu XA.

Zhonghua Wai Ke Za Zhi. 2004 Feb 7;42(3):137-9. Chinese.

PMID:
15062056
14.

Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM.

Hum Pathol. 2010 Jan;41(1):48-58. doi: 10.1016/j.humpath.2009.06.007. Epub 2009 Sep 5.

PMID:
19733895
15.

B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.

Zhang W, Hou T, Niu C, Song L, Zhang Y.

PLoS One. 2015 Dec 28;10(12):e0144360. doi: 10.1371/journal.pone.0144360. eCollection 2015.

16.

[Significance of chemokine receptor CXCR3 expression in breast cancer].

Li L, Chen J, Lu ZH, Yu SN, Luo YF, Zhao WG, Ma YH, Jia CW.

Zhonghua Bing Li Xue Za Zhi. 2011 Feb;40(2):85-8. Chinese.

PMID:
21426802
17.
18.

Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.

Amara S, Chaar I, Khiari M, Ounissi D, Weslati M, Boughriba R, Hmida AB, Bouraoui S.

Cancer Biomark. 2015;15(6):869-79. doi: 10.3233/CBM-150531.

PMID:
26406413
19.

Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.

Lin Y, Liu F, Fan Y, Qian X, Lang R, Gu F, Gu J, Fu L.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8028-37. eCollection 2015.

20.

High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease.

Wang J, Ma J, Dong Y, Shen Z, Ma H, Wang X, Shi S, Wu J, Lu G, Peng L, Zhoud X.

APMIS. 2013 Jan;121(1):30-7. doi: 10.1111/j.1600-0463.2012.02941.x. Epub 2012 Jul 12.

PMID:
23030051

Supplemental Content

Support Center